New Ebola vaccine trial 100 percent effective

New Ebola vaccine trial 100 percent effective.
New Ebola vaccine trial 100 percent effective. | Courtesy of sciencedaily.com
According to a recent report from The Guardian, an Ebola vaccine trial that took place in Guinea and involved 4,000 people is considered 100 percent effective in protecting people against Ebola.

The AIDS Healthcare Foundation (AHF) is now urging public health and world leaders to pool their resources in developing this vaccine and delivering it to the people who need it the most first, namely West Africans. People continue to contract and die from Ebola. As of today, 27,748 people have contract Ebola infections, and 11,279 people have died from the disease.

Two physicians with the AHF, Dr. John Taban Dada and Dr. Sheik Humarr Khan, have died from Ebola.

“After a poorly managed global response to the Ebola outbreak last year, news of the phenomenal successes of these vaccine trials in Guinea—100 percent efficacy in a trial cohort of 4,000 patients—is simply tremendous,” Michael Weinstein, president of AIDS Healthcare Foundation, said. “World leaders such as the United States, the U.K. and others as well as leading global public health organizations must step up now with all due haste and all financial resources necessary to quickly bring this vaccine to development and to those in need, particularly in West Africa, where people are still contracting—and dying—of Ebola."

Organizations in this Story

AIDS Healthcare Foundation

Want to get notified whenever we write about AIDS Healthcare Foundation ?
Next time we write about AIDS Healthcare Foundation, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.